WO2024257116 - NOVEL POLYMORPHIC FORMS OF ASCIMINIB AND ITS PHARMACEUTICAL SALTS THEREOF

National phase entry is expected:
Publication Number WO/2024/257116
Publication Date 19.12.2024
International Application No. PCT/IN2024/050651
International Filing Date 31.05.2024
Title **
[English] NOVEL POLYMORPHIC FORMS OF ASCIMINIB AND ITS PHARMACEUTICAL SALTS THEREOF
[French] NOUVELLES FORMES POLYMORPHES D'ASCIMINIB ET LEURS SELS PHARMACEUTIQUES
Applicants **
NATCO PHARMA LIMITED Natco House, Road No.2 Banjara Hills Hyderabad 500034, IN
Inventors
TALASANI, Shyam Sunder Reddy Natco House, Road No.2 Banjara Hills. Hyderabad 500034, IN
CIRUSANAGANDLA, Venkateshwar Rao Natco House, Road No.2 Banjara Hills. HYderabad 500034, IN
YAJJUVARAPU, Rushyarao Natco House, Road No.2 Banjara Hills. Hyderabad 500034, IN
KOTTE, Rajashekar Natco House, Road No.2 Banjara Hills. Hyderabad 500034, IN
KASUGANTI, Jayakrishna Natco House, Road No.2 Banjara Hills. HYderabad 500034, IN
ABAYEE KALIYAPERUMAL, Srinivasan Natco House, Road No.2 Banjara Hills. Hyderabad 500034, IN
RAMPALLI, Sriram Natco House, Road No.2 Banjara Hills. Hyderabad 500034, IN
MUDDASANI, Pulla Reddy Natco House, Road No.2 Banjara Hills. Hyderabad 500034, IN
NANNAPANENI, Venkaiah Chowdary Natco House, Road No.2 Banjara Hills. Hyderabad 500034, IN
Priority Data
202341040211   13.06.2023   IN
front page image
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
*
International Searching Authority
*
Applicant's Legal Status
*
*
*
*
*
Entry into National Phase under
*
Translation

Recalculate

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing1074
EPO Filing, Examination6428
Japan Filing595
South Korea Filing574
USA Filing, Examination5710
MasterCard Visa

Total: 14381

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Abstract[English] The present invention relates to an improved process for the preparation of Asciminib comprising novel process intermediates. The invention also described the novel polymorphic forms of Asciminib and its pharmaceutical salts.[French] La présente invention concerne un procédé amélioré pour la préparation d'asciminib comprenant de nouveaux intermédiaires de traitement. L'invention concerne également de nouvelles formes polymorphes d'asciminib et leurs sels pharmaceutiques.
An unhandled error has occurred. Reload 🗙